Sunshine Biopharma Inc short interest was 68.28% of the float on May 29th, according to new data we received from Benzinga. Short interest totaled 1,443,031 shares, which was an increase of 190.86% from May 15th.
It is estimated that it would take 1.0 days for short sellers to buy back their shares, with current trading volumes.
Sunshine Biopharma Inc Hedge Fund Activity
We have seen 5 institutional investors add shares of Sunshine Biopharma Inc stock to their portfolio, and 12 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RENAISSANCE TECHNOLOGIES LLC removed 55,700 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $68,511
- DRW SECURITIES, LLC removed 44,977 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $55,321
- TWO SIGMA SECURITIES, LLC added 23,482 shares (+inf%) to their portfolio in Q1 2026, for an estimated $24,421
- VIRTU FINANCIAL LLC removed 23,388 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $24,323
- TWO SIGMA INVESTMENTS, LP removed 21,399 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $26,320
- COMMONWEALTH EQUITY SERVICES, LLC added 13,437 shares (+inf%) to their portfolio in Q1 2026, for an estimated $13,974
- CITADEL ADVISORS LLC removed 7,681 shares (-14.2%) from their portfolio in Q1 2026, for an estimated $7,988
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
